Family    O
"    O
Leptospiraceae    B-Moneran101342269
"    O

These    O
include    O
but    O
are    O
not    O
limited    O
to    O
"    O
B.    O
burgdorferi    O
"    O
s.s    O
.    O
"    O
,    O
B.    B-Moneran101342269
afzelii    I-Moneran101342269
,    O
B.    B-Moneran101342269
garinii    I-Moneran101342269
,    O
B.    B-Moneran101342269
valaisana    I-Moneran101342269
,    O
"    O
B.    B-Moneran101342269
Lusitaniae    I-Moneran101342269
"    O
,    O
B.    B-Moneran101342269
andersoni    I-Moneran101342269
,    O
25015    O
,    O
DN127    O
,    O
CA55    O
,    O
25015    O
,    O
HK501    O
,    O
B.    B-Moneran101342269
Miyamotoi    I-Moneran101342269
"    O
,    O
and    O
"    O
B.    B-Moneran101342269
Japonica.    I-Moneran101342269

"    O
M.    B-Moneran101342269
kubicae    I-Moneran101342269
"    O

Mycobacterium    B-Moneran101342269
tusciae    I-Moneran101342269
is    O
a    O
slow    O
-    O
growing    O
,    O
scotochromogenic    O
mycobacterium    O
first    O
isolated    O
from    O
a    O
lymph    O
node    O
of    O
an    O
immunocompromised    O
child    O
and    O
subsequently    O
from    O
tap    O
water    O
and    O
from    O
a    O
respiratory    O
specimen    O
of    O
a    O
patient    O
with    O
chronic    O
fibrosis    O
.    O

Erythema    O
chronicum    O
migrans    O
due    O
to    O
Borrelia    B-Moneran101342269
burgdorferi    I-Moneran101342269

There    O
is    O
some    O
evidence    O
that    O
"    O
Ixodes    O
ricinus    O
"    O
infected    O
with    O
"    O
Borrelia    B-Moneran101342269
burgdorferi    I-Moneran101342269
"    O
may    O
become    O
more    O
efficient    O
at    O
infestation    O
.    O

Lymerix    O
works    O
on    O
the    O
outer    O
surface    O
protein    O
A    O
(    O
Osp    O
-    O
A    O
)    O
of    O
Borrelia    B-Moneran101342269
burgdorferi    I-Moneran101342269
,    O
the    O
causative    O
agent    O
of    O
Lyme    O
Disease    O
.    O

Bacterial    O
(    O
"    O
Brucella    O
"    O
,    O
"    O
Corynebacterium    O
diphtheriae    O
"    O
,    O
gonococcus    O
,    O
"    O
Haemophilus    O
influenzae    O
"    O
,    O
"    O
Actinomyces    O
"    O
,    O
'    O
'    O
Tropheryma    O
whipplei    O
"    O
,    O
"    O
Vibrio    O
cholerae    O
"    O
,    O
"    O
Borrelia    B-Moneran101342269
burgdorferi    I-Moneran101342269
"    O
,    O
leptospirosis    O
,    O
and    O
Rickettsia    O
,    O
"    O
Mycoplasma    O
pneumoniae    O
"    O
)    O

The    O
BlyA    O
membrane    O
protein    O
and    O
the    O
BlyB    O
soluble    O
accessory    O
protein    O
are    O
encoded    O
on    O
the    O
conserved    O
cp32    O
plasmid    O
of    O
"    O
Borrelia    B-Moneran101342269
burgdorferi    I-Moneran101342269
,    O
"    O
which    O
can    O
be    O
packaged    O
into    O
a    O
bacteriophage    O
particle    O
.    O

Introduction    O
of    O
the    O
"    O
Borrelia    B-Moneran101342269
burgdorferi    I-Moneran101342269
"    O
"    O
blyAB    O
"    O
locus    O
into    O
"    O
Escherichia    O
coli    O
"    O
produces    O
a    O
hemolytic    O
phenotype    O
that    O
is    O
dependent    O
on    O
the    O
"    O
E.    O
coli    O
clyA    O
(    O
hlyE    O
,    O
sheA    O
)    O
"    O
gene    O
(    O
TC    O
#    O
1.C.10.1.1    O
)    O
.    O

"    O
Borrelia    O
"    O
species    O
,    O
such    O
as    O
"    O
Borrelia    B-Moneran101342269
burgdorferi    I-Moneran101342269
"    O
,    O
a    O
tick    O
-    O
borne    O
bacterium    O
that    O
causes    O
Lyme    O
disease    O

"    O
Borrelia    B-Moneran101342269
burgdorferi    I-Moneran101342269
"    O

Pathogens    O
that    O
have    O
been    O
shown    O
to    O
recruit    O
factor    O
H    O
include    O
:    O
Aspergillus    O
spp    O
.    O
;    O
Borrelia    B-Moneran101342269
burgdorferi    I-Moneran101342269
;    O
B.    O
duttonii    O
;    O
B.    B-Moneran101342269
recurrentis    I-Moneran101342269
;    O
Candida    O
albicans    O
;    O
Francisella    O
tularensis    O
;    O
Haemophilus    O
influenzae    O
;    O
Neisseria    O
meningitidis    O
;    O
Streptococcus    O
Pneumoniae    O
;    O
and    O
Streptococcus    O
pyogenes    O
.    O

The    O
Siberian    O
accentor    O
is    O
parasitised    O
by    O
the    O
taiga    O
tick    O
,    O
which    O
can    O
host    O
the    O
spirochaete    O
"    O
Borrelia    B-Moneran101342269
burgdorferi    I-Moneran101342269
"    O
,    O
the    O
cause    O
of    O
Lyme    O
disease    O
.    O

These    O
include    O
but    O
are    O
not    O
limited    O
to    O
"    O
B.    O
burgdorferi    O
"    O
s.s    O
.    O
"    O
,    O
B.    B-Moneran101342269
afzelii    I-Moneran101342269
,    O
B.    B-Moneran101342269
garinii    I-Moneran101342269
,    O
B.    B-Moneran101342269
valaisana    I-Moneran101342269
,    O
"    O
B.    B-Moneran101342269
Lusitaniae    I-Moneran101342269
"    O
,    O
B.    B-Moneran101342269
andersoni    I-Moneran101342269
,    O
25015    O
,    O
DN127    O
,    O
CA55    O
,    O
25015    O
,    O
HK501    O
,    O
B.    B-Moneran101342269
Miyamotoi    I-Moneran101342269
"    O
,    O
and    O
"    O
B.    B-Moneran101342269
Japonica.    I-Moneran101342269

"    O
M.    B-Moneran101342269
mageritense    I-Moneran101342269
"    O

Mycobacterium    B-Moneran101342269
colombiense    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

"    O
Halobacterium    B-Moneran101342269
noricense    I-Moneran101342269
"    O

Mycobacterium    B-Moneran101342269
cookii    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Mycobacterium    B-Moneran101342269
wolinskyi    I-Moneran101342269
is    O
a    O
rapidly    O
growing    O
mycobacterium    O
most    O
commonly    O
seen    O
in    O
post    O
-    O
traumatic    O
wound    O
infections    O
,    O
especially    O
those    O
following    O
open    O
fractures    O
and    O
with    O
associated    O
osteomyelitis    O
.    O
"    O

Mycobacterium    B-Moneran101342269
houstonense    I-Moneran101342269
is    O
a    O
member    O
of    O
the    O
"    O
Mycobacterium    B-Moneran101342269
fortuitum    I-Moneran101342269
"    O
third    O
biovariant    O
complex    O
.    O

Mycobacterium    B-Moneran101342269
bohemicum    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

"    O
Mycobacterium    O
neworleansense    O
"    O
is    O
a    O
member    O
of    O
the    O
Mycobacterium    B-Moneran101342269
fortuitum    I-Moneran101342269
third    O
biovariant    O
complex    O
.    O

Mycobacterium    O
wolinskyi    O
"    O
is    O
clearly    O
clinically    O
significant    O
,    O
and    O
occurs    O
in    O
the    O
same    O
settings    O
as    O
Mycobacterium    O
smegmatis    O
and    O
members    O
of    O
the    O
Mycobacterium    B-Moneran101342269
fortuitum    I-Moneran101342269
complex    O
;    O
they    O
differ    O
from    O
members    O
of    O
the    O
Mycobacterium    B-Moneran101342269
fortuitum    I-Moneran101342269
complex    O
in    O
the    O
type    O
of    O
chronic    O
lung    O
disease    O
they    O
produce    O
,    O
with    O
essentially    O
all    O
cases    O
occurring    O
in    O
the    O
setting    O
of    O
chronic    O
lipoid    O
pneumonia    O
,    O
either    O
secondary    O
to    O
chronic    O
oil    O
ingestion    O
or    O
chronic    O
aspiration    O
(    O
usually    O
achalasia    O
)    O
.    O

"    O
M.    B-Moneran101342269
lentiflavum    I-Moneran101342269

Mycobacterium    B-Moneran101342269
genavense    I-Moneran101342269
is    O
a    O
slow    O
-    O
growing    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Mycobacterium    B-Moneran101342269
canariasense    I-Moneran101342269
is    O
a    O
rapidly    O
growing    O
,    O
non    O
-    O
pigmented    O
mycobacterium    O
first    O
isolated    O
from    O
blood    O
samples    O
obtained    O
from    O
17    O
patients    O
with    O
febrile    O
syndrome    O
.    O

Leptospira    B-Moneran101342269
weilii    I-Moneran101342269
is    O
a    O
pathogenic    O
species    O
of    O
Leptospira    O
.    O

These    O
include    O
but    O
are    O
not    O
limited    O
to    O
"    O
B.    O
burgdorferi    O
"    O
s.s    O
.    O
"    O
,    O
B.    B-Moneran101342269
afzelii    I-Moneran101342269
,    O
B.    B-Moneran101342269
garinii    I-Moneran101342269
,    O
B.    B-Moneran101342269
valaisana    I-Moneran101342269
,    O
"    O
B.    B-Moneran101342269
Lusitaniae    I-Moneran101342269
"    O
,    O
B.    B-Moneran101342269
andersoni    I-Moneran101342269
,    O
25015    O
,    O
DN127    O
,    O
CA55    O
,    O
25015    O
,    O
HK501    O
,    O
B.    B-Moneran101342269
Miyamotoi    I-Moneran101342269
"    O
,    O
and    O
"    O
B.    B-Moneran101342269
Japonica.    I-Moneran101342269

"    O
M.    B-Moneran101342269
lacus    I-Moneran101342269
"    O

Mycobacterium    B-Moneran101342269
gadium    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

"    O
M.    B-Moneran101342269
kumamotonense    I-Moneran101342269
"    O

The    O
closest    O
neighbors    O
that    O
show    O
the    O
most    O
similarity    O
to    O
"    O
M.    O
elephantis    O
"    O
are    O
"    O
M.    B-Moneran101342269
confluentis    I-Moneran101342269
"    O
at    O
97.8%    O
and    O
"    O
M.    B-Moneran101342269
phlei    I-Moneran101342269
"    O
at    O
97.7%    O
.    O

The    O
Brachyspira    O
"    O
holin    O
(    O
B    O
-    O
Hol    O
)    O
Family    O
"    O
'    O
(    O
TC    O
#    O
1.E.55    O
)    O
consists    O
of    O
several    O
proteins    O
from    O
the    O
GTA    O
holin    O
of    O
"    O
Brachyspira    B-Moneran101342269
hyodysenteriae    O
"    O
(    O
TC    O
#    O
1.E.55.1.1    O
)    O
,    O
which    O
facilitates    O
gene    O
transfer    O
agent    O
-    O
release    O
(    O
see    O
also    O
GTA    O
holin    O
family    O
)    O
to    O
VSH-1    O
holin    O
of    O
"    O
Brachyspira    B-Moneran101342269
pilosicoli    I-Moneran101342269
.    O
"    O

The    O
compound    O
4,21-dimethyl-5,19-di-(trans)-enoyl    O
-    O
heptatriacontanoic    O
acid    O
is    O
the    O
"    O
structure    O
of    O
the    O
major    O
homolog    O
of    O
free    O
mycobacteric    O
acids    O
"    O
of    O
"    O
Mycobacterium    B-Moneran101342269
brumae    I-Moneran101342269
"    O
.    O

Mycobacterium    B-Moneran101342269
hodleri    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

"    O
Borrelia    B-Moneran101342269
miyamotoi    I-Moneran101342269
"    O

"    O
M.    B-Moneran101342269
madagascariense    I-Moneran101342269
"    O

"    O
M.    B-Moneran101342269
komossense    I-Moneran101342269
"    O

Which    O
unifies    O
rapidly    O
growing    O
,    O
scotochromogenic    O
mycobacteria    O
(    O
M.    O
parafortuitum    O
,    O
Mycobacterium    B-Moneran101342269
aurum    I-Moneran101342269
,    O
Mycobacterium    B-Moneran101342269
neoaurum    I-Moneran101342269
,    O
"    O
M.    O
diernhoferi    O
"    O
and    O
Mycobacterium    B-Moneran101342269
austroafricanum    I-Moneran101342269
)    O
.    O

"    O
Borrelia    B-Moneran101342269
hermsii    I-Moneran101342269
"    O

It    O
was    O
named    O
by    O
the    O
UK    O
Antarctic    O
Place    O
-    O
Names    O
Committee    O
for    O
Robert    O
Koch    O
,    O
the    O
pioneer    O
German    O
bacteriologist    O
who    O
discovered    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
,    O
the    O
bacterium    O
responsible    O
for    O
most    O
cases    O
of    O
tuberculosis    O
.    O

The    O
most    O
common    O
organisms    O
which    O
cause    O
lobar    O
pneumonia    O
are    O
"    O
Streptococcus    O
pneumoniae    O
"    O
,    O
also    O
called    O
pneumococcus    O
,    O
"    O
Haemophilus    O
influenzae    O
"    O
and    O
"    O
Moraxella    O
catarrhalis    O
"    O
.    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
,    O
the    O
tubercle    O
bacillus    O
,    O

Such    O
pathogens    O
include    O
"    O
Streptococcus    O
pneumoniae    O
"    O
,    O
"    O
Haemophilus    O
influenzae    O
"    O
and    O
the    O
highly    O
infectious    O
"    O
M    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
,    O
which    O
are    O
transmitted    O
by    O
inhaling    O
aerosols    O
.    O

"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
(    O
tuberculosis    O
)    O

Other    O
bacteria    O
,    O
such    O
as    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
,    O
live    O
inside    O
a    O
protective    O
capsule    O
that    O
prevents    O
lysis    O
by    O
complement    O
.    O

In    O
size    O
and    O
shape    O
,    O
it    O
closely    O
resembles    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
.    O

Comparing    O
the    O
genome    O
sequence    O
of    O
"    O
M.    O
leprae    O
"    O
with    O
that    O
of    O
"    O
M.    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
provides    O
clear    O
explanations    O
for    O
these    O
properties    O
,    O
and    O
reveals    O
an    O
extreme    O
case    O
of    O
reductive    O
evolution    O
.    O

In    O
1879    O
,    O
he    O
stained    O
these    O
organisms    O
with    O
Ziehl    O
's    O
method    O
and    O
noted    O
the    O
similarities    O
with    O
Koch    O
's    O
bacillus    O
(    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
)    O
.    O

Among    O
the    O
most    O
important    O
bacteria    O
known    O
to    O
occur    O
in    O
indoor    O
air    O
are    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
,    O
Staphylococcus    O
aureus    O
,    O
Streptococcus    O
pneumoniae    O
.    O

Capreomycin    O
is    O
most    O
commonly    O
used    O
to    O
treat    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
infections    O
.    O
"    O
Mycobacterium    O
tuberculosis    O
"    O
growth    O
has    O
been    O
found    O
to    O
be    O
inhibited    O
at    O
a    O
concentration    O
of    O
2.5    O
μg    O
/    O
mL.    O

Expression    O
of    O
IL-15    O
can    O
be    O
stimulated    O
by    O
cytokine    O
such    O
as    O
GM    O
-    O
CSF    O
,    O
double    O
-    O
strand    O
mRNA    O
,    O
unmethylated    O
CpG    O
oligonucleotides    O
,    O
lipopolysaccharide    O
(    O
LPS    O
)    O
through    O
Toll    O
-    O
like    O
receptors    O
(    O
TLR    O
)    O
,    O
interferon    O
gamma    O
(    O
IFN-γ    O
)    O
or    O
after    O
infection    O
of    O
monocytes    O
herpes    O
virus    O
,    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
and    O
"    O
Candida    O
albicans    O
"    O
(    O
Figure    O
2    O
)    O
.    O

"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
α-isopropylmalate    O
synthase    O
requires    O
a    O
divalent    O
metal    O
ion    O
,    O
of    O
which    O
Mg2    O
+    O
and    O
Mn2    O
+    O
give    O
highest    O
activity    O
,    O
and    O
a    O
monovalent    O
cation    O
,    O
with    O
K+    O
as    O
the    O
best    O
activator    O
.    O

"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
,    O
the    O
cause    O
of    O
tuberculosis    O
,    O
evades    O
effective    O
immune    O
clearance    O
through    O
encapsulation    O
,    O
especially    O
with    O
mycolic    O
acids    O
that    O
are    O
particularly    O
resistant    O
to    O
the    O
normal    O
degradative    O
processes    O
of    O
macrophages    O
.    O

Crystal    O
structures    O
of    O
FabH    O
have    O
been    O
reported    O
from    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
,    O
{    O
"    O
Staphylococcus    O
aureus    O
"    O
,    O
"    O
Escherichia    O
coli    O
"    O
,    O
and    O
"    O
Thermus    O
thermophilus    O
"    O
.    O

This    O
pathway    O
is    O
especially    O
important    O
to    O
M.    B-Moneran101342269
tuberculosis    I-Moneran101342269
,    O
allowing    O
long    O
-    O
term    O
persistence    O
of    O
its    O
infection    O
.    O

When    O
the    O
M.    B-Moneran101342269
tuberculosis    I-Moneran101342269
becomes    O
phagocytosed    O
,    O
the    O
bacterium    O
upregulates    O
genes    O
encoding    O
the    O
glyoxylate    O
shunt    O
enzymes    O
.    O

It    O
is    O
the    O
most    O
common    O
"    O
M.    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
skin    O
infection    O
.    O

One    O
of    O
the    O
bacterial    O
diseases    O
with    O
the    O
highest    O
disease    O
burden    O
is    O
tuberculosis    O
,    O
caused    O
by    O
the    O
bacterium    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
,    O
which    O
kills    O
about    O
2    O
million    O
people    O
a    O
year    O
,    O
mostly    O
in    O
sub    O
-    O
Saharan    O
Africa    O
.    O

"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O

He    O
was    O
the    O
first    O
scientist    O
to    O
produce    O
photomicrographs    O
of    O
the    O
tubercule    B-Moneran101342269
bacillus    I-Moneran101342269
.    O

"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O

Antibacterial    O
activity    O
is    O
most    O
pronounced    O
against    O
fast    O
-    O
growing    O
mycobacteria    O
and    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
,    O
and    O
the    O
growth    O
of    O
both    O
chloroquine    O
-    O
resistant    O
"    O
Plasmodium    O
falciparum    O
"    O
strains    O
is    O
also    O
inhibited    O
.    O

HMB    O
-    O
PP    O
is    O
an    O
essential    O
metabolite    O
in    O
most    O
pathogenic    O
bacteria    O
including    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
and    O
malaria    O
parasites    O
,    O
but    O
is    O
absent    O
from    O
the    O
human    O
host    O
.    O

At    O
the    O
age    O
of    O
71    O
,    O
Hart    O
published    O
a    O
seminal    O
paper    O
in    O
the    O
"    O
Journal    O
of    O
Experimental    O
Medicine    O
"    O
,    O
showing    O
that    O
the    O
intracellular    O
pathogen    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
avoids    O
destruction    O
in    O
the    O
cell    O
's    O
lysosomes    O
by    O
circumventing    O
these    O
organelles    O
altogether    O
—    O
a    O
trick    O
now    O
known    O
to    O
be    O
used    O
by    O
many    O
other    O
intracellular    O
pathogens    O
.    O

Because    O
it    O
was    O
already    O
known    O
that    O
leprosy    O
and    O
tuberculosis    O
were    O
both    O
caused    O
by    O
mycobacteria    O
(    O
"    O
Mycobacterium    B-Moneran101342269
leprae    I-Moneran101342269
"    O
and    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
,    O
respectively    O
)    O
,    O
Guy    O
Henry    O
Faget    O
of    O
the    O
National    O
Leprosarium    O
in    O
Carville    O
,    O
Louisiana    O
,    O
requested    O
information    O
about    O
the    O
drug    O
from    O
Parke    O
-    O
Davis    O
.    O

ESAT-6    O
,    O
the    O
6    O
kDa    O
early    O
secretory    O
antigenic    O
target    O
produced    O
by    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
,    O
is    O
a    O
secretory    O
protein    O
and    O
potent    O
T    O
cell    O
antigen    O
.    O

CFP-10    O
is    O
a    O
10    O
kDa    O
secreted    O
antigen    O
from    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
.    O

10-kDa    O
culture    O
filtrate    O
protein    O
(    O
CFP-10    O
)    O
is    O
an    O
antigen    O
that    O
contributes    O
to    O
the    O
virulence    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
.    O

In    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
,    O
the    O
core    O
components    O
of    O
the    O
whole    O
ESX-1    O
secretion    O
system    O
include    O
Rv3877    O
,    O
and    O
two    O
AAA    O
ATPases    O
,    O
including    O
Rv3870    O
and    O
Rv3871    O
,    O
a    O
cytosolic    O
protein    O
.    O

The    O
ESAT-6/CFP-10    O
complex    O
’s    O
secretion    O
and    O
attachment    O
to    O
the    O
virulent    O
host    O
cell    O
shows    O
its    O
contribution    O
to    O
the    O
pathogenicity    O
of    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
.    O
[    O
4    O
]    O
.    O

Resistance    O
of    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
to    O
isoniazid    O
,    O
rifampin    O
,    O
and    O
other    O
common    O
treatments    O
has    O
become    O
an    O
increasingly    O
relevant    O
clinical    O
challenge    O
.    O

It    O
is    O
not    O
susceptible    O
to    O
antituberculosis    O
drugs    O
(    O
which    O
can    O
generally    O
kill    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
)    O
.    O

There    O
is    O
a    O
strong    O
correlation    O
between    O
mutations    O
in    O
pncA    O
and    O
resistance    O
of    O
"    O
M.    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
to    O
pyrazinamide    O
.    O

"    O
Mycobacterium    O
vaccae    O
"    O
is    O
in    O
the    O
same    O
genus    O
as    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
,    O
the    O
bacterium    O
which    O
causes    O
tuberculosis    O
.    O

It    O
did    O
not    O
differ    O
from    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
in    O
the    O
biochemical    O
tests    O
and    O
in    O
its    O
16S    O
rRNA    O
sequence    O
.    O

Following    O
the    O
cloning    O
of    O
MscL    O
,    O
the    O
crystal    O
structure    O
of    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
MscL    O
(    O
Tb    O
-    O
MscL    O
)    O
,    O
was    O
obtained    O
in    O
its    O
closed    O
conformation    O
.    O

"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
contains    O
at    O
least    O
nine    O
small    O
RNA    O
families    O
in    O
its    O
genome    O
.    O

Serpulina    B-Moneran101342269
hyodysenteriae    I-Moneran101342269
,    O
formerly    O
known    O
as    O
"    O
Brachyspira    O
hyodysenteriae    O
"    O
and    O
"    O
Treponema    O
hyodysenteriae    O
"    O
,    O
is    O
a    O
species    O
of    O
bacteria    O
.    O

Differentiated    O
from    O
the    O
phenotypic    O
closely    O
related    O
M.    B-Moneran101342269
thermoresistibile    I-Moneran101342269
by    O
its    O
inability    O
to    O
grow    O
at    O
52°C    O
.    O

Mycobacterium    B-Moneran101342269
branderi    I-Moneran101342269
is    O
a    O
slowly    O
growing    O
,    O
nonchromogenic    O
Mycobacterium    O
first    O
isolated    O
from    O
patients    O
in    O
Finland    O
.    O

"    O
M.    B-Moneran101342269
nonchromogenicum    I-Moneran101342269
"    O

Mycobacterium    B-Moneran101342269
hiberniae    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Suggested    O
name    O
for    O
"    O
Mycobacterium    B-Moneran101342269
avium    I-Moneran101342269
avium    I-Moneran101342269
"    O
isolates    O
from    O
humans    O
and    O
pigs    O
.    O

Mycobacterium    B-Moneran101342269
intermedium    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

"    O
Leptospira    B-Moneran101342269
interrogans    I-Moneran101342269
"    O

Mycobacterium    B-Moneran101342269
nebraskense    I-Moneran101342269
is    O
a    O
slow    O
growing    O
,    O
yellow    O
,    O
pigmented    O
mycobacterium    O
that    O
was    O
first    O
isolated    O
from    O
human    O
sputum    O
at    O
the    O
University    O
of    O
Nebraska    O
Medical    O
Center    O
,    O
in    O
Omaha    O
,    O
Nebraska    O
,    O
USA    O
.    O

Mycobacterium    B-Moneran101342269
fluoranthenivorans    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Rapid-growing    B-Moneran101342269
"Mycobacterium"    I-Moneran101342269
infection    I-Moneran101342269

Mycobacterium    B-Moneran101342269
celatum    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

The    O
Brachyspira    O
"    O
holin    O
(    O
B    O
-    O
Hol    O
)    O
Family    O
"    O
'    O
(    O
TC    O
#    O
1.E.55    O
)    O
consists    O
of    O
several    O
proteins    O
from    O
the    O
GTA    O
holin    O
of    O
"    O
Brachyspira    B-Moneran101342269
hyodysenteriae    O
"    O
(    O
TC    O
#    O
1.E.55.1.1    O
)    O
,    O
which    O
facilitates    O
gene    O
transfer    O
agent    O
-    O
release    O
(    O
see    O
also    O
GTA    O
holin    O
family    O
)    O
to    O
VSH-1    O
holin    O
of    O
"    O
Brachyspira    B-Moneran101342269
pilosicoli    I-Moneran101342269
.    O
"    O

"    O
B.    B-Moneran101342269
garinii    I-Moneran101342269
"    O

The    O
species    O
"    O
Treponema    B-Moneran101342269
hyodysenteriae    I-Moneran101342269
"    O
and    O
"    O
Treponema    O
innocens    O
"    O
have    O
been    O
reclassified    O
into    O
"    O
Serpulina    B-Moneran101342269
hyodysenteriae    I-Moneran101342269
"    O
and    O
"    O
Serpulina    B-Moneran101342269
innocens    I-Moneran101342269
"    O
.    O

It    O
may    O
also    O
be    O
used    O
for    O
atypical    O
types    O
of    O
mycobacteria    O
,    O
such    O
as    O
"    O
M.    O
avium    O
"    O
,    O
"    O
M.    B-Moneran101342269
kansasii    I-Moneran101342269
"    O
,    O
and    O
"    O
M.    B-Moneran101342269
xenopi    I-Moneran101342269
"    O
.    O

Which    O
unifies    O
rapidly    O
growing    O
,    O
scotochromogenic    O
mycobacteria    O
(    O
M.    O
parafortuitum    O
,    O
Mycobacterium    B-Moneran101342269
aurum    I-Moneran101342269
,    O
Mycobacterium    B-Moneran101342269
neoaurum    I-Moneran101342269
,    O
"    O
M.    O
diernhoferi    O
"    O
and    O
Mycobacterium    B-Moneran101342269
austroafricanum    I-Moneran101342269
)    O
.    O

This    O
species    O
is    O
the    O
newest    O
identifiable    O
mycobacterial    O
organism    O
to    O
thrive    O
in    O
these    O
settings    O
,    O
joining    O
other    O
rapid    O
growing    O
species    O
,    O
Mycobacterium    B-Moneran101342269
fortuitum    I-Moneran101342269
,    O
Mycobacterium    B-Moneran101342269
chelonae    I-Moneran101342269
,    O
and    O
Mycobacterium    O
abscessus    O
,    O
that    O
have    O
been    O
found    O
in    O
previous    O
outbreaks    O
.    O

It    O
is    O
also    O
used    O
for    O
infections    O
by    O
"    O
Mycobacterium    O
avium    O
"    O
,    O
"    O
M.    O
abcessus    O
"    O
,    O
"    O
M.    B-Moneran101342269
chelonae    I-Moneran101342269
"    O
,    O
and    O
"    O
M.    B-Moneran101342269
fortuitum    I-Moneran101342269
"    O
.    O

#    O
"    O
Mycobacterium    O
avium    O
"    O
complex    O
or    O
"    O
Mycobacterium    B-Moneran101342269
kansasii    I-Moneran101342269
"    O
,    O
disseminated    O
or    O
extrapulmonary    O

Infection    O
due    O
to    O
Mycobacterium    B-Moneran101342269
kansasii    I-Moneran101342269

Examples    O
include    O
"    O
Clostridium    O
tetani    O
"    O
and    O
"    O
Staphylococcus    O
aureus    O
"    O
(    O
from    O
spines    O
and    O
thorns    O
)    O
,    O
"    O
Sporothrix    O
schenckii    O
"    O
(    O
from    O
rose    O
thorns    O
,    O
grasses    O
,    O
and    O
sphagnum    O
moss    O
)    O
,    O
"    O
Mycobacterium    B-Moneran101342269
kansasii    I-Moneran101342269
"    O
(    O
from    O
blackberries    O
)    O
,    O
"    O
Mycobacterium    O
marinum    O
"    O
(    O
from    O
cactus    O
spines    O
)    O
,    O
and    O
"    O
Mycobacterium    O
ulcerans    O
"    O
(    O
from    O
spiky    O
tropical    O
vegetation    O
)    O
.    O

Mycobacterium    B-Moneran101342269
avium    I-Moneran101342269
subsp.    I-Moneran101342269
silvaticum    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

:    O
"    O
M.    B-Moneran101342269
microti    I-Moneran101342269
"    O

"    O
Spirochaeta    B-Moneran101342269
americana    I-Moneran101342269
"    O
Hoover    O
et    O
al    O
.    O
2003    O

Mycobacterium    B-Moneran101342269
cosmeticum    I-Moneran101342269
is    O
a    O
rapidly    O
growing    O
mycobacterium    O
that    O
was    O
first    O
isolated    O
from    O
cosmetic    O
patients    O
and    O
sites    O
performing    O
cosmetic    O
procedures    O
.    O

Mycobacterium    B-Moneran101342269
agri    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

"    O
M.    B-Moneran101342269
sphagni    I-Moneran101342269
"    O

Chancre    O
is    O
a    O
lesion    O
typical    O
of    O
infection    O
with    O
the    O
bacterium    O
that    O
causes    O
syphilis    O
,    O
Treponema    B-Moneran101342269
pallidum    I-Moneran101342269

Less    O
common    O
bacterial    O
causes    O
include    O
:    O
"    O
Staphylococcus    O
aureus    O
"    O
(    O
including    O
methicillin    O
resistant    O
Staphylococcus    O
aureus    O
or    O
MRSA    O
)    O
,    O
"    O
Streptococcus    O
pneumoniae    O
"    O
,    O
"    O
Mycoplasma    O
pneumoniae    O
"    O
,    O
"    O
Chlamydia    O
pneumoniae    O
"    O
,    O
"    O
Bordetella    O
pertussis    O
"    O
,    O
"    O
Fusobacterium    O
"    O
sp    O
.    O
,    O
"    O
Corynebacterium    O
diphtheriae    O
"    O
,    O
"    O
Treponema    B-Moneran101342269
pallidum    I-Moneran101342269
"    O
,    O
and    O
"    O
Neisseria    O
gonorrhoeae    O
"    O
.    O

"    O
Treponema    O
"    O
species    O
,    O
such    O
as    O
"    O
Treponema    B-Moneran101342269
pallidum    I-Moneran101342269
"    O
,    O
subspecies    O
of    O
which    O
causes    O
treponematoses    O
,    O
including    O
syphilis    O

Thin    O
spirochete    O
"    O
Treponema    B-Moneran101342269
pallidum    I-Moneran101342269
"    O
bacteria    O
,    O
the    O
causative    O
agent    O
of    O
syphilis    O
magnified    O
400    O
times    O
.    O

Crosby    O
says    O
that    O
the    B-Moneran101342269
bacterium    I-Moneran101342269
that    I-Moneran101342269
causes    I-Moneran101342269
syphilis    I-Moneran101342269
belongs    O
to    O
the    O
same    O
phylogenetic    O
family    O
as    O
the    O
bacteria    O
that    O
cause    O
yaws    O
and    O
several    O
other    O
diseases    O
.    O

While    O
working    O
at    O
the    O
Rockefeller    O
University    O
(    O
then    O
called    O
the    O
Rockefeller    O
Institute    O
for    O
Medical    O
Research    O
)    O
in    O
1913    O
,    O
Hideyo    O
Noguchi    O
,    O
a    O
Japanese    O
scientist    O
,    O
demonstrated    O
the    O
presence    O
of    O
the    O
spirochete    O
"    O
Treponema    B-Moneran101342269
pallidum    I-Moneran101342269
"    O
in    O
the    O
brain    O
of    O
a    O
progressive    O
paralysis    O
patient    O
,    O
associating    O
"    O
Treponema    O
pallidum    O
"    O
with    O
neurosyphilis    O
.    O

"    O
Treponema    B-Moneran101342269
pallidum    I-Moneran101342269
"    O

Often    O
these    O
babies    O
will    O
develop    O
syphilitic    O
rhinitis    O
(    O
"    O
snuffles    O
"    O
)    O
,    O
the    O
mucus    O
from    O
which    O
is    O
laden    O
with    O
the    O
"    O
T.    B-Moneran101342269
pallidum    I-Moneran101342269
"    O
bacterium    O
,    O
and    O
therefore    O
highly    O
infectious    O
.    O

He    O
was    O
the    O
first    O
to    O
describe    O
his    O
triad    O
of    O
medical    O
signs    O
for    O
congenital    O
syphilis    O
:    O
notched    O
incisor    O
teeth    O
,    O
labyrinthine    O
deafness    O
and    O
interstitial    O
keratitis    O
,    O
which    O
was    O
very    O
useful    O
for    O
providing    O
a    O
firm    O
diagnosis    O
long    O
before    O
the    O
"    O
Treponema    B-Moneran101342269
pallidum    I-Moneran101342269
"    O
or    O
the    O
Wassermann    O
test    O
were    O
discovered    O
.    O

Mycobacterium    B-Moneran101342269
flavescens    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Borrelia    B-Moneran101342269
turicatae    I-Moneran101342269
is    O
a    O
bacterial    O
species    O
of    O
the    O
spirochaete    O
class    O
of    O
the    O
genus    O
"    O
Borrelia    O
"    O
.    O
"    O

Mycobacterium    B-Moneran101342269
psychrotolerans    I-Moneran101342269
is    O
a    O
rapidly    O
growing    O
mycobacterium    O
first    O
isolated    O
from    O
pond    O
water    O
near    O
a    O
uranium    O
mine    O
in    O
Spain    O
.    O

Mycobacterium    B-Moneran101342269
aubagnense    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

"    O
Treponema    B-Moneran101342269
primitia    I-Moneran101342269
"    O
Graber    O
et    O
al    O
.    O
2004    O

Mycobacterium    B-Moneran101342269
florentinum    I-Moneran101342269
is    O
a    O
strain    O
of    O
bacteria    O
found    O
in    O
humans    O
that    O
can    O
cause    O
infections    O
and    O
other    O
disease    O
conditions    O
,    O
and    O
prolong    O
sickness    O
.    O

M.    O
conceptionense    O
shares    O
99.7%    O
16S    O
rRNA    O
(    O
4-bp    O
difference    O
)    O
and    O
97.0%    O
rpoB    O
gene    O
sequence    O
similarity    O
with    O
Mycobacterium    B-Moneran101342269
porcinum    I-Moneran101342269
,    O
the    O
nearest    O
species    O
.    O

"    O
Borrelia    B-Moneran101342269
parkeri    I-Moneran101342269
"    O

Pathogens    O
that    O
have    O
been    O
shown    O
to    O
recruit    O
factor    O
H    O
include    O
:    O
Aspergillus    O
spp    O
.    O
;    O
Borrelia    B-Moneran101342269
burgdorferi    I-Moneran101342269
;    O
B.    O
duttonii    O
;    O
B.    B-Moneran101342269
recurrentis    I-Moneran101342269
;    O
Candida    O
albicans    O
;    O
Francisella    O
tularensis    O
;    O
Haemophilus    O
influenzae    O
;    O
Neisseria    O
meningitidis    O
;    O
Streptococcus    O
Pneumoniae    O
;    O
and    O
Streptococcus    O
pyogenes    O
.    O

"    O
M.    B-Moneran101342269
massiliense    I-Moneran101342269
"    O

Mycobacterium    B-Moneran101342269
duvalii    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

It    O
was    O
first    O
isolated    O
from    O
petroleum    O
-    O
contaminated    O
estuarine    O
sediments    O
and    O
has    O
been    O
shown    O
by    O
16S    O
rRNA    O
gene    O
sequencing    O
to    O
be    O
closely    O
related    O
to    O
Mycobacterium    B-Moneran101342269
aurum    I-Moneran101342269
and    O
Mycobacterium    O
vaccae    O
.    O
"    O

"    O
M.    B-Moneran101342269
triviale    I-Moneran101342269
"    O

Mycobacterium    B-Moneran101342269
hassiacum    I-Moneran101342269
is    O
a    O
rapid    O
-    O
growing    O
thermophilic    O
mycobacterium    O
that    O
was    O
isolated    O
in    O
human    O
urine    O
in    O
1997    O
by    O
researchers    O
at    O
the    O
German    O
University    O
of    O
Regensburg    O
.    O

"    O
M.    B-Moneran101342269
shottsii    I-Moneran101342269
"    O

This    O
search    O
led    O
to    O
the    O
discovery    O
of    O
the    O
bacterium    O
GFAJ-1    B-Moneran101342269
,    O
which    O
her    O
team    O
claimed    O
in    O
a    O
"    O
Science    O
"    O
on    O
-    O
line    O
article    O
in    O
December    O
2010    O
was    O
able    O
to    O
incorporate    O
arsenate    O
as    O
a    O
substitute    O
for    O
a    O
small    O
percentage    O
of    O
the    O
typical    O
phosphate    O
in    O
its    O
DNA    O
and    O
other    O
essential    O
biomolecules    O
.    O

A    O
2010    O
experiment    O
involving    O
the    O
bacteria    O
GFAJ-1    B-Moneran101342269
that    O
made    O
this    O
claim    O
was    O
refuted    O
by    O
2012    O
.    O

Mycobacterium    B-Moneran101342269
goodii    I-Moneran101342269
is    O
an    O
acid    O
-    O
fast    O
bacterial    O
species    O
in    O
the    O
phylum    O
"    O
Actinobacteria    O
"    O
and    O
the    O
genus    O
"    O
Mycobacterium    O
"    O
.    O

Mycobacterium    B-Moneran101342269
pinnipedii    I-Moneran101342269
is    O
a    O
member    O
of    O
the    O
Mycobacterium    O
tuberculosis    O
complex    O
which    O
primarily    O
infects    O
seals    O
.    O

Leptospira    B-Moneran101342269
santarosai    I-Moneran101342269
is    O
a    O
pathogenic    O
species    O
of    O
Leptospira    O
.    O

"    O
M.    B-Moneran101342269
septicum    I-Moneran101342269
"    O

Mycobacterium    B-Moneran101342269
immunogenum    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Debaryomyces    B-Moneran101342269
hansenii    I-Moneran101342269

Mycobacterium    B-Moneran101342269
heidelbergense    I-Moneran101342269
is    O
a    O
Gram    O
-    O
positive    O
,    O
nonmotile    O
,    O
acid    O
-    O
fast    O
coccobacillus    O
.    O

In    O
the    O
1980s    O
,    O
Dieter    O
Oesterhelt    O
’s    O
laboratory    O
showed    O
for    O
the    O
first    O
time    O
that    O
haloarchaea    B-Moneran101342269
switch    O
the    O
rotation    O
of    O
their    O
archaellum    O
from    O
clockwise    O
to    O
counterclockwise    O
up    O
on    O
blue    O
light    O
pulses    O
.    O

Halorhodopsin    O
is    O
a    O
light    O
-    O
gated    O
ion    O
pump    O
,    O
specific    O
for    O
chloride    O
ions    O
,    O
found    O
in    O
archaea    O
,    O
known    O
as    O
halobacteria    B-Moneran101342269
.    O

Halorhodopsin    O
isoforms    O
can    O
be    O
found    O
in    O
multiple    O
species    O
of    O
halobacteria    B-Moneran101342269
,    O
including    O
"    O
Halobacterium    B-Moneran101342269
salinarum    I-Moneran101342269
"    O
,    O
and    O
"    O
Natronobacterium    O
pharaonis    O
"    O
.    O

Halobacteria    B-Moneran101342269

Haloarchaea    B-Moneran101342269
do    O
not    O
have    O
chloroplasts    O
or    O
chlorophyll    O
,    O
and    O
instead    O
rely    O
on    O
the    O
protein    O
bacteriorhodopsin    O
as    O
proton    O
pumps    O
,    O
capturing    O
light    O
energy    O
and    O
using    O
it    O
to    O
create    O
a    O
proton    O
gradient    O
that    O
is    O
subsequently    O
converted    O
into    O
chemical    O
energy    O
.    O

Russell    O
Vreeland    O
,    O
and    O
colleagues    O
from    O
West    O
Chester    O
University    O
in    O
Pennsylvania    O
,    O
reported    O
on    O
October    O
18    O
,    O
2000    O
that    O
they    O
had    O
revived    O
the    O
halobacteria    B-Moneran101342269
after    O
bathing    O
them    O
with    O
a    O
nutrient    O
solution    O
.    O

This    O
section    O
lists    O
the    O
genera    O
of    O
Archaea    O
within    O
the    O
Class    O
Halobacteria    B-Moneran101342269
.    O

Mycobacterium    B-Moneran101342269
palustre    I-Moneran101342269
is    O
a    O
slowly    O
growing    O
mycobacterium    O
first    O
isolated    O
from    O
an    O
environmental    O
source    O
in    O
Finland    O
.    O

"    O
Treponema    B-Moneran101342269
isoptericolens    I-Moneran101342269
"    O
Dröge    O
et    O
al    O
.    O
2008    O

"Mycobacterium    B-Moneran101342269
avium    I-Moneran101342269
hominissuis"    I-Moneran101342269
is    O
a    O
subspecies    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

"    O
Treponema    B-Moneran101342269
bryantii    I-Moneran101342269
"    O
Stanton    O
and    O
Canale    O
-    O
Parola    O
1980    O

Mycobacterium    B-Moneran101342269
chitae    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

"    O
M.    B-Moneran101342269
malmoense    I-Moneran101342269
"    O

Periodontal    O
diseases    O
take    O
on    O
many    O
different    O
forms    O
but    O
are    O
usually    O
a    O
result    O
of    O
a    O
coalescence    O
of    O
bacterial    O
plaque    O
biofilm    O
accumulation    O
of    O
the    O
red    O
complex    O
bacteria    O
(    O
e.g.    O
,    O
P.    O
gingivalis    O
,    O
T.    O
forsythia    O
,    O
and    O
T.    B-Moneran101342269
denticola    I-Moneran101342269
)    O
of    O
the    O
gingiva    O
and    O
teeth    O
,    O
combined    O
with    O
host    O
immuno    O
-    O
inflammatory    O
mechanisms    O
and    O
other    O
risk    O
factors    O
which    O
lead    O
to    O
destruction    O
of    O
the    O
supporting    O
bone    O
around    O
natural    O
teeth    O
.    O

The    O
canonical    O
PAM    O
is    O
associated    O
with    O
the    O
Cas9    O
nuclease    O
of    O
Streptococcus    O
pyogenes    O
(    O
designated    O
SpCas9    O
)    O
,    O
whereas    O
different    O
PAMs    O
are    O
associated    O
with    O
the    O
Cas9    O
proteins    O
of    O
the    O
bacteria    O
Neisseria    O
meningitidis    O
,    O
Treponema    B-Moneran101342269
denticola    I-Moneran101342269
,    O
and    O
Streptococcus    O
thermophilus    O
.    O

Mycobacterium    B-Moneran101342269
frederiksbergense    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Mycobacterium    B-Moneran101342269
interjectum    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Mycobacterium    B-Moneran101342269
pyrenivorans    I-Moneran101342269
is    O
a    O
scotochromogenic    O
,    O
rapidly    O
growing    O
mycobacterium    O
,    O
first    O
isolated    O
from    O
an    O
enrichment    O
culture    O
obtained    O
from    O
soil    O
that    O
was    O
highly    O
contaminated    O
with    O
polycyclic    O
aromatic    O
hydrocarbons    O
(    O
PAHs    O
)    O
.    O

Belongs    O
to    O
the    O
"    O
Mycobacterium    B-Moneran101342269
parafortuitum    I-Moneran101342269
"    O
complex    O
.    O

Mycobacterium    B-Moneran101342269
conspicuum    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Mycobacterium    B-Moneran101342269
vanbaalenii    I-Moneran101342269
is    O
a    O
rapidly    O
growing    O
mycobacterium    O
that    O
can    O
use    O
polycyclic    O
aromatic    O
hydrocarbons    O
.    O

Mycobacterium    B-Moneran101342269
boenickei    I-Moneran101342269
is    O
a    O
member    O
of    O
the    O
Mycobacterium    B-Moneran101342269
fortuitum    I-Moneran101342269
third    O
biovariant    O
complex    O
.    O

Mycobacterium    B-Moneran101342269
doricum    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Mycobacterium    B-Moneran101342269
caprae    I-Moneran101342269
is    O
a    O
species    O
of    O
bacteria    O
in    O
the    O
genus    O
"    O
Mycobacterium    O
"    O
and    O
a    O
member    O
of    O
the    O
Mycobacterium    O
tuberculosis    O
complex    O
.    O

"    O
M.    B-Moneran101342269
poriferae    I-Moneran101342269
"    O

"    O
M.    B-Moneran101342269
pulveris    I-Moneran101342269
"    O

In    O
1984    O
,    O
it    O
was    O
renamed    O
"    O
Borrelia    B-Moneran101342269
duttoni    I-Moneran101342269
"    O
.    O

Closely    O
related    O
to    O
Mycobacterium    B-Moneran101342269
aichiense    I-Moneran101342269
and    O
Mycobacterium    B-Moneran101342269
farcinogenes    I-Moneran101342269
,    O
rapidly    O
growing    O
mycobacteria    O
,    O
by    O
evaluation    O
of    O
16S    O
rDNA    O
sequences    O
.    O

Mycobacterium    B-Moneran101342269
elephantis    I-Moneran101342269
,    O
a    O
bacterium    O
of    O
the    O
family    O
Mycobacteriaceae    O
,    O
was    O
discovered    O
and    O
isolated    O
from    O
a    O
deceased    O
elephant    O
near    O
India    O
and    O
may    O
be    O
linked    O
to    O
respiratory    O
dysfunction    O
.    O

Mycobacterium    B-Moneran101342269
canettii    I-Moneran101342269
,    O
a    O
novel    O
pathogenic    O
taxon    O
of    O
the    O
"    O
Mycobacterium    O
tuberculosis    O
"    O
complex    O
(    O
MTBC    O
)    O
,    O
was    O
first    O
reported    O
in    O
1969    O
by    O
the    O
French    O
microbiologist    O
Georges    O
Canetti    O
,    O
for    O
whom    O
the    O
organism    O
has    O
been    O
named    O
.    O

Mycobacterium    B-Moneran101342269
holsaticum    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Mycobacterium    B-Moneran101342269
diernhoferi    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Mycobacterium    B-Moneran101342269
gordonae    I-Moneran101342269
is    O
a    O
species    O
of    O
"    O
Mycobacterium    O
"    O
named    O
for    O
Ruth    O
E.    O
Gordon    O
.    O

Most    O
closely    O
related    O
to    O
Mycobacterium    B-Moneran101342269
diernhoferi    I-Moneran101342269
and    O
Mycobacterium    B-Moneran101342269
mucogenicum    I-Moneran101342269
.    O

The    O
closest    O
neighbors    O
that    O
show    O
the    O
most    O
similarity    O
to    O
"    O
M.    O
elephantis    O
"    O
are    O
"    O
M.    B-Moneran101342269
confluentis    I-Moneran101342269
"    O
at    O
97.8%    O
and    O
"    O
M.    B-Moneran101342269
phlei    I-Moneran101342269
"    O
at    O
97.7%    O
.    O

Mycobacterium    B-Moneran101342269
fallax    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
Actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
"    O
Mycobacterium    O
"    O
.    O

These    O
include    O
but    O
are    O
not    O
limited    O
to    O
"    O
B.    O
burgdorferi    O
"    O
s.s    O
.    O
"    O
,    O
B.    B-Moneran101342269
afzelii    I-Moneran101342269
,    O
B.    B-Moneran101342269
garinii    I-Moneran101342269
,    O
B.    B-Moneran101342269
valaisana    I-Moneran101342269
,    O
"    O
B.    B-Moneran101342269
Lusitaniae    I-Moneran101342269
"    O
,    O
B.    B-Moneran101342269
andersoni    I-Moneran101342269
,    O
25015    O
,    O
DN127    O
,    O
CA55    O
,    O
25015    O
,    O
HK501    O
,    O
B.    B-Moneran101342269
Miyamotoi    I-Moneran101342269
"    O
,    O
and    O
"    O
B.    B-Moneran101342269
Japonica.    I-Moneran101342269

"    O
B.    B-Moneran101342269
pilosicoli    I-Moneran101342269
"    O
can    O
infect    O
humans    O
leading    O
to    O
human    O
intestinal    O
spirochaetosis    O
,    O
however    O
most    O
cases    O
of    O
HIS    O
are    O
caused    O
by    O
"    O
B.    B-Moneran101342269
aalborgi    I-Moneran101342269
"    O
,    O
so    O
its    O
clinical    O
relevance    O
remains    O
unclear    O
.    O

?    O
"    O
Treponema    B-Moneran101342269
carateum    I-Moneran101342269
"    O
♥    O
(    O
pinta    O
causing    O
"    O
Treponema    O
"    O
)    O

"    O
M.    B-Moneran101342269
obuense    I-Moneran101342269
"    O

Cristispira    B-Moneran101342269
is    O
a    O
genus    O
of    O
bacteria    O
of    O
the    O
spirochete    O
phylum    O
.    O

Mycobacterium    B-Moneran101342269
conceptionense    I-Moneran101342269
is    O
a    O
non    O
pigmented    O
rapidly    O
growing    O
mycobacterium    O
was    O
first    O
isolated    O
from    O
wound    O
liquid    O
outflow    O
,    O
bone    O
tissue    O
biopsy    O
,    O
and    O
excised    O
skin    O
tissue    O
from    O
a    O
31-year    O
-    O
old    O
woman    O
who    O
suffered    O
an    O
accidental    O
open    O
right    O
tibia    O
fracture    O
and    O
prolonged    O
stay    O
in    O
a    O
river    O
.    O

Mycobacterium    B-Moneran101342269
chlorophenolicum    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Mycobacterium    B-Moneran101342269
asiaticum    I-Moneran101342269
is    O
a    O
slowly    O
growing    O
photochromogenic    O
mycobacterium    O
first    O
isolated    O
from    O
monkeys    O
in    O
1965    O
.    O
"    O

"    O
M.    B-Moneran101342269
monacense    I-Moneran101342269
"    O

Mycobacterium    B-Moneran101342269
botniense    I-Moneran101342269
is    O
a    O
slowly    O
growing    O
Mycobacterium    O
,    O
which    O
produces    O
a    O
yellow    O
pigment    O
.    O

Mycobacterium    B-Moneran101342269
gilvum    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Because    O
of    O
this    O
abundance    O
,    O
the    O
"    O
M.    O
tuberculosis    O
"    O
along    O
with    O
"    O
Mycobacterium    B-Moneran101342269
canetti    I-Moneran101342269
"    O
and    O
varied    O
types    O
of    O
"    O
Mycobacterium    B-Moneran101342269
africanum    I-Moneran101342269
"    O
release    O
the    O
excess    O
niacin    O
into    O
their    O
outside    O
environment    O
,    O
in    O
this    O
case    O
,    O
the    O
agar    O
plate    O
or    O
another    O
medium    O
.    O

They    O
are    O
important    O
in    O
the    O
nitrogen    O
cycle    O
.    O
The    O
species    O
"    O
Spirillum    B-Moneran101342269
minus    I-Moneran101342269
"    O
causes    O
rat    O
-    O
bite    O
fever    O
.    O

Nocardia    O
farcinica    O
is    O
a    O
species    O
of    O
bacteria    O
and    O
a    O
member    O
of    O
the    O
genus    O
"    O
Nocardia    B-Moneran101342269
"    O
.    O

In    O
the    O
brain    O
,    O
it    O
can    O
occur    O
with    O
an    O
early    O
brain    O
abscess    O
as    O
well    O
as    O
in    O
"    O
Nocardia    B-Moneran101342269
"    O
infections    O
associated    O
with    O
lung    O
cavitary    O
lesions    O
.    O

This    O
family    O
contains    O
three    O
potentially    O
pathogenic    O
genera    O
:    O
"    O
Actinomyces    O
,    O
Nocardia    B-Moneran101342269
,    O
"    O
and    O
"    O
Streptomyces    O
.    O
"    O

"    O
Nocardia    B-Moneran101342269
"    O
spp    O
.    O

Species    O
from    O
the    O
following    O
genera    O
are    O
known    O
to    O
synthesize    O
B12    O
:    O
"    O
Acetobacterium    O
"    O
,    O
"    O
Aerobacter    O
"    O
,    O
"    O
Agrobacterium    O
"    O
,    O
"    O
Alcaligenes    O
"    O
,    O
"    O
Azotobacter    O
"    O
,    O
"    O
Bacillus    O
"    O
,    O
"    O
Clostridium    O
"    O
,    O
"    O
Corynebacterium    O
"    O
,    O
"    O
Flavobacterium    O
"    O
,    O
"    O
Lactobacillus    O
"    O
,    O
"    O
Micromonospora    O
"    O
,    O
"    O
Mycobacterium    O
"    O
,    O
"    O
Nocardia    B-Moneran101342269
"    O
,    O

Other    O
groups    O
of    O
intracellular    O
bacterial    O
pathogens    O
include    O
"    O
Salmonella    O
"    O
,    O
"    O
Neisseria    O
"    O
,    O
"    O
Brucella    O
"    O
,    O
"    O
Mycobacterium    O
"    O
,    O
"    O
Nocardia    B-Moneran101342269
,    O
"    O
"    O
Listeria    O
"    O
,    O
"    O
Francisella    O
"    O
,    O
"    O
Legionella    O
"    O
,    O
and    O
"    O
Yersinia    O
pestis    O
"    O
.    O

In    O
all    O
of    O
the    O
preceding    O
traits    O
and    O
in    O
their    O
branching    O
filament    O
formation    O
,    O
they    O
bear    O
similarities    O
to    O
"    O
Nocardia    B-Moneran101342269
"    O
.    O

Mycobacterium    B-Moneran101342269
alvei    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

G.    O
H.    O
A.    O
Hansen    O
,    O
discoverer    O
of    O
"    O
M.    B-Moneran101342269
leprae    I-Moneran101342269
"    O
in    O
1873    O
.    O

Neisser    O
also    O
codiscovered    O
the    O
pathogen    O
that    O
causes    O
leprosy    O
,    O
"    O
Mycobacterium    B-Moneran101342269
leprae    I-Moneran101342269
"    O
.    O

"    O
Mycobacterium    B-Moneran101342269
leprae    I-Moneran101342269
"    O

in    O
which    O
"    O
Mycobacterium    B-Moneran101342269
leprae    I-Moneran101342269
"    O
was    O
discovered    O
to    O
have    O
a    O
significantly    O
higher    O
percentage    O
of    O
pseudogenes    O
to    O
functional    O
genes    O
(    O
~40%    O
)    O
than    O
its    O
free    O
-    O
living    O
ancestors    O
.    O

Because    O
it    O
was    O
already    O
known    O
that    O
leprosy    O
and    O
tuberculosis    O
were    O
both    O
caused    O
by    O
mycobacteria    O
(    O
"    O
Mycobacterium    B-Moneran101342269
leprae    I-Moneran101342269
"    O
and    O
"    O
Mycobacterium    B-Moneran101342269
tuberculosis    I-Moneran101342269
"    O
,    O
respectively    O
)    O
,    O
Guy    O
Henry    O
Faget    O
of    O
the    O
National    O
Leprosarium    O
in    O
Carville    O
,    O
Louisiana    O
,    O
requested    O
information    O
about    O
the    O
drug    O
from    O
Parke    O
-    O
Davis    O
.    O

They    O
are    O
particularly    O
susceptible    O
due    O
to    O
their    O
unusually    O
low    O
body    O
temperature    O
,    O
which    O
is    O
hospitable    O
to    O
the    O
leprosy    O
bacterium    O
,    O
"    O
Mycobacterium    B-Moneran101342269
leprae    I-Moneran101342269
"    O
.    O

In    O
one    O
of    O
his    O
few    O
scientific    O
errors    O
,    O
he    O
was    O
firmly    O
convinced    O
that    O
there    O
was    O
a    O
link    O
between    O
getting    O
leprosy    O
and    O
eating    O
salted    O
or    O
rotted    O
fish    O
,    O
even    O
after    O
the    O
pathogenic    O
agent    O
,    O
"    O
Mycobacterium    B-Moneran101342269
leprae    I-Moneran101342269
"    O
was    O
discovered    O
in    O
1873    O
.    O

Its    O
mission    O
was    O
to    O
systematically    O
eliminate    O
leprosy    O
,    O
(    O
Hansen    O
's    O
disease    O
)    O
,    O
a    O
readily    O
transmissible    O
,    O
previously    O
incurable    O
,    O
chronic    O
infectious    O
disease    O
caused    O
by    O
M.    B-Moneran101342269
leprae    I-Moneran101342269
,    O
from    O
each    O
prefecture    O
in    O
Japan    O
.    O

"    O
Leptospira    B-Moneran101342269
noguchii    I-Moneran101342269
"    O

Mycobacterium    B-Moneran101342269
chubuense    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

Mycobacterium    B-Moneran101342269
haemophilum    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
Actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
"    O
Mycobacterium    O
"    O
.    O

Closely    O
related    O
to    O
Mycobacterium    B-Moneran101342269
aichiense    I-Moneran101342269
and    O
Mycobacterium    B-Moneran101342269
farcinogenes    I-Moneran101342269
,    O
rapidly    O
growing    O
mycobacteria    O
,    O
by    O
evaluation    O
of    O
16S    O
rDNA    O
sequences    O
.    O

"    O
Mycobacterium    B-Moneran101342269
phocaicum    I-Moneran101342269
"    O

Halobacterium    B-Moneran101342269
salinarum    I-Moneran101342269
is    O
an    O
extremely    O
halophilic    O
marine    O
Gram    O
-    O
negative    O
obligate    O
aerobic    O
archaeon    O
.    O

"    O
H.    O
volcanii    O
"    O
respire    O
as    O
their    O
sole    O
source    O
of    O
ATP    O
,    O
unlike    O
several    O
other    O
halobateriacae    O
,    O
such    O
as    O
"    O
Halobacterium    B-Moneran101342269
salinarum    I-Moneran101342269
"    O
they    O
are    O
incapable    O
of    O
photophosphorylation    O
as    O
they    O
lack    O
the    O
necessary    O
bacteriorhodopsin    O
.    O

It    O
is    O
closely    O
related    O
to    O
the    O
non    O
-    O
pathogenic    O
,    O
also    O
slowly    O
growing    O
,    O
nonpigmented    O
,    O
"    O
M.    B-Moneran101342269
gastri    I-Moneran101342269
"    O
.    O

"    O
M.    B-Moneran101342269
tokaiense    I-Moneran101342269
"    O

Pasteurization    O
was    O
first    O
used    O
in    O
the    O
United    O
States    O
in    O
the    O
1890s    O
after    O
the    O
discovery    O
of    O
germ    O
theory    O
to    O
control    O
the    O
hazards    O
of    O
highly    O
contagious    O
bacterial    O
diseases    O
,    O
including    O
bovine    B-Moneran101342269
tuberculosis    I-Moneran101342269
and    O
brucellosis    O
,    O
that    O
could    O
be    O
easily    O
transmitted    O
to    O
humans    O
through    O
the    O
drinking    O
of    O
raw    O
milk    O
.    O

Milk    O
collected    O
or    O
stored    O
in    O
unsanitary    O
conditions    O
may    O
harbor    O
a    O
host    O
of    O
disease    O
-    O
causing    O
organisms    O
(    O
pathogens    O
)    O
,    O
such    O
as    O
"    O
tuberculosis    O
"    O
(    O
Mycobacterium    B-Moneran101342269
bovis    I-Moneran101342269
)    O
,    O
the    O
bacteria    O
"    O
Campylobacter    O
"    O
(    O
Campylobacteriosis    O
)    O
,    O
"    O
Escherichia    O
"    O
E.    O
coli    O
O157:H7    O
)    O
,    O
"    O
Listeria    O
"    O
(    O
Listeriosis    O
)    O
,    O
"    O
Salmonella    O
"    O
(    O
Salmonellosis    O
)    O
,    O
"    O
Yersinia    O
"    O
(    O
Yersinia    O
enterocolitica    O
)    O
,    O
and    O
"    O
Brucella    O
"    O
(    O
Brucellosis    O
)    O
.    O

Breeders    O
can    O
utilise    O
cattle    O
husbandry    O
to    O
reduce    O
M.    B-Moneran101342269
bovis    I-Moneran101342269
infection    I-Moneran101342269
susceptibility    O
by    O
selective    O
breeding    O
and    O
maintaining    O
herd    O
health    O
to    O
avoid    O
concurrent    O
disease    O
.    O

From    O
the    O
1970s    O
to    O
the    O
90s    O
,    O
however    O
,    O
the    O
population    O
began    O
to    O
decline    O
again    O
with    O
the    O
spread    O
of    O
bovine    B-Moneran101342269
tuberculosis    I-Moneran101342269
which    O
resulted    O
from    O
the    O
transfer    O
of    O
infected    O
plains    O
bison    O
to    O
Wood    O
Buffalo    O
National    O
Park    O
.    O

Due    O
to    O
an    O
outbreak    O
of    O
"    O
Mycobacterium    B-Moneran101342269
bovis    I-Moneran101342269
"    O
(    O
bovine    O
tuberculosis    O
)    O
in    O
the    O
founder    O
generation    O
,    O
a    O
"    O
buffer    O
generation    O
"    O
was    O
introduced    O
in    O
the    O
herd    O
.    O

development    O
of    O
a    O
control    O
for    O
bovine    B-Moneran101342269
tuberculosis    I-Moneran101342269

"    O
MUT    O
"    O
has    O
also    O
been    O
linked    O
to    O
bovine    B-Moneran101342269
tuberculosis    I-Moneran101342269
(    O
bTB    O
)    O
,    O
a    O
form    O
of    O
tuberculosis    O
that    O
affects    O
mostly    O
livestock    O
and    O
accounts    O
for    O
10%    O
of    O
human    O
cases    O
.    O

Established    O
by    O
Congress    O
to    O
combat    O
a    O
wide    O
range    O
of    O
animal    O
diseases    O
—    O
from    O
infectious    O
disease    O
of    O
swine    O
to    O
bovine    B-Moneran101342269
pneumonia    I-Moneran101342269
,    O
Texas    O
cattle    O
fever    O
to    O
glanders—    O

Other    O
infectious    O
diseases    O
affecting    O
wild    O
animals    O
,    O
farm    O
animals    O
and    O
humans    O
include    O
rabies    O
,    O
leptospirosis    O
,    O
brucellosis    O
,    O
tuberculosis    B-Moneran101342269
and    O
trichinosis    O
.    O

Two    O
inspectors    O
from    O
the    O
Northern    O
Territory    O
Department    O
of    O
Primary    O
Industry    O
and    O
Fisheries    O
,    O
as    O
part    O
of    O
a    O
government    O
-    O
sponsored    O
campaign    O
to    O
eradicate    O
brucellosis    O
and    O
tuberculosis    B-Moneran101342269
in    O
cattle    O
,    O
told    O
the    O
Mengels    O
that    O
there    O
were    O
restrictions    O
on    O
the    O
movement    O
of    O
their    O
cattle    O
which    O
meant    O
they    O
were    O
only    O
able    O
to    O
be    O
moved    O
to    O
an    O
abattoir    O
for    O
slaughter    O
.    O

Because    O
of    O
this    O
and    O
the    O
fact    O
that    O
cows    O
are    O
a    O
natural    O
host    O
of    O
Mycobacterium    B-Moneran101342269
bovis    I-Moneran101342269
,    O
a    O
pathogen    O
in    O
humans    O
as    O
well    O
,    O
it    O
is    O
hoped    O
that    O
studying    O
cows    O
will    O
yield    O
insights    O
into    O
the    O
group    O
1    O
CD1    O
antigen    O
-    O
presenting    O
system    O
.    O

He    O
spent    O
most    O
of    O
World    O
War    O
II    O
in    O
Puerto    O
Rico    O
and    O
the    O
Virgin    O
Islands    O
,    O
where    O
he    O
coordinated    O
milk    O
and    O
food    O
sanitation    O
programs    O
,    O
evaluated    O
zoonotic    O
threats    O
to    O
the    O
islands    O
,    O
and    O
conducted    O
research    O
on    O
brucellosis    O
,    O
bovine    B-Moneran101342269
tuberculosis    I-Moneran101342269
,    O
rabies    O
,    O
and    O
Venezuelan    O
equine    O
encephalitis    O
.    O

"    O
M.    B-Moneran101342269
lepraemurium    I-Moneran101342269
"    O

Mycobacterium    B-Moneran101342269
arupense    I-Moneran101342269
is    O
a    O
rapidly    O
growing    O
mycobacterium    O
first    O
isolated    O
from    O
soil    O
and    O
human    O
sputum    O
samples    O
in    O
Spain    O
.    O

Spirillum    O
is    O
a    O
genus    O
of    O
Gram    O
-    O
negative    O
bacteria    O
within    O
family    O
Spirillaceae    B-Moneran101342269
.    O

Brachyspiraceae    B-Moneran101342269
is    O
a    O
family    O
of    O
spirochaetes    O
.    O

The    O
Spirochaetaceae    B-Moneran101342269
are    O
a    O
family    O
of    O
spirochete    O
bacteria    O
.    O

"    O
B.    B-Moneran101342269
afzelii    I-Moneran101342269
"    O

Up    O
to    O
now    O
there    O
is    O
only    O
on    O
species    O
of    O
this    O
genus    O
known    O
(    O
Diplocalyx    B-Moneran101342269
calotermitidis    I-Moneran101342269
)    O
.    O

"    O
M.    B-Moneran101342269
montefiorense    I-Moneran101342269
"    O

Mycobacterium    B-Moneran101342269
heckeshornense    I-Moneran101342269
is    O
a    O
species    O
of    O
the    O
phylum    O
actinobacteria    O
(    O
Gram    O
-    O
positive    O
bacteria    O
with    O
high    O
guanine    O
and    O
cytosine    O
content    O
,    O
one    O
of    O
the    O
dominant    O
phyla    O
of    O
all    O
bacteria    O
)    O
,    O
belonging    O
to    O
the    O
genus    O
mycobacterium    O
.    O

"    O
M.    B-Moneran101342269
moriokaense    I-Moneran101342269
"    O

Mycobacterium    B-Moneran101342269
bolletii    I-Moneran101342269
is    O
a    O
bacterial    O
species    O
of    O
the    O
phylum    O
Actinobacteria    O
and    O
the    O
genus    O
"    O
Mycobacterium    O
"    O
.    O

"    O
Treponema    B-Moneran101342269
azotonutricium    I-Moneran101342269
"    O
Graber    O
et    O
al    O
.    O
2004    O


